Tapewire

Nasdaq · USD

BCYC

BICYCLE THERAPEUTICS PLC

Export transactions ↓
Tapewire entity
5993
SEC CIK
0001761612
Parsed reports
304

Last 12 months

Inside the activity.

0 purchase rows · 49 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 2026013
Feb 202600
Mar 202600
Apr 2026011
May 202600
Jun 202600
Jul 2026011
Aug 202600
Sep 202600
Oct 2026014

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2024 Filed Jan 4, 2024 18:30 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000881 · doc4.xml · derivative · entry 2

Kender Richard N · CIK 0001381205 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Ordinary Shares · 12,000 shares

Expires 2034-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 18:30 UTC GrantOrdinary Shares 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000881 · doc4.xml · nonDerivative · entry 1

Kender Richard N · CIK 0001381205 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,750

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 18:35 UTC GrantStock Option (right to buy) · Derivative 24,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000889 · doc4.xml · derivative · entry 2

Legault Pierre · CIK 0001391045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Ordinary Shares · 24,000 shares

Expires 2034-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 18:35 UTC GrantOrdinary Shares 12,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000889 · doc4.xml · nonDerivative · entry 1

Legault Pierre · CIK 0001391045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,500

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 18:29 UTC
Arroyo SantiagoChief Development Officer
GrantEmployee Stock Option (right to buy) · Derivative 35,430 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000880 · doc4.xml · derivative · entry 2

Arroyo Santiago · CIK 0001706857 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,430

Underlying: Ordinary Shares · 35,430 shares

Expires 2034-01-02

F3 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 18:29 UTC
Arroyo SantiagoChief Development Officer
GrantOrdinary Shares 17,340 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000880 · doc4.xml · nonDerivative · entry 1

Arroyo Santiago · CIK 0001706857 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,340

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:36 UTC
Thompson Travis AlvinChief Accounting Officer
GrantEmployee Stock Option (right to buy) · Derivative 31,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000890 · doc4.xml · derivative · entry 3

Thompson Travis Alvin · CIK 0001983944 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Ordinary Shares · 31,000 shares

Expires 2034-01-02

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:36 UTC
Thompson Travis AlvinChief Accounting Officer
GrantOrdinary Shares 16,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000890 · doc4.xml · nonDerivative · entry 1

Thompson Travis Alvin · CIK 0001983944 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,979

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:31 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000882 · doc4.xml · derivative · entry 2

Winter Gregory Paul · CIK 0001777021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Ordinary Shares · 12,000 shares

Expires 2034-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:31 UTC GrantOrdinary Shares 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000882 · doc4.xml · nonDerivative · entry 1

Winter Gregory Paul · CIK 0001777021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,677

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:28 UTC
Crockett NigelChief Business Officer
GrantEmployee Stock Option (right to buy) · Derivative 44,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000879 · doc4.xml · derivative · entry 3

Crockett Nigel · CIK 0001788580 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Ordinary Shares · 44,000 shares

Expires 2034-01-02

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:28 UTC
Crockett NigelChief Business Officer
GrantOrdinary Shares 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000879 · doc4.xml · nonDerivative · entry 1

Crockett Nigel · CIK 0001788580 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,359

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:27 UTC
Young AlethiaChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 24,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000878 · doc4.xml · derivative · entry 2

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Ordinary Shares · 24,000 shares

Expires 2034-01-02

F3 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:27 UTC
Young AlethiaChief Financial Officer
GrantOrdinary Shares 12,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000878 · doc4.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:27 UTC
Milnes AlistairChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 77,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000877 · doc4.xml · derivative · entry 3

Milnes Alistair · CIK 0001901321 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Ordinary Shares · 77,000 shares

Expires 2034-01-02

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:27 UTC
Milnes AlistairChief Operating Officer
GrantOrdinary Shares 39,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000877 · doc4.xml · nonDerivative · entry 1

Milnes Alistair · CIK 0001901321 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,839

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:26 UTC
Skynner MichaelChief Technology Officer
GrantEmployee Stock Option (right to buy) · Derivative 56,000 $0.00 Strike: $18.08 $0.00
Disclosure

SEC source: 0001209191-24-000876 · doc4.xml · derivative · entry 3

Skynner Michael · CIK 0001776582 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Ordinary Shares · 56,000 shares

Expires 2034-01-02

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:26 UTC
Skynner MichaelChief Technology Officer
GrantOrdinary Shares 28,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000876 · doc4.xml · nonDerivative · entry 1

Skynner Michael · CIK 0001776582 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,482

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 17:49 UTC
Keen NicholasChief Scientific Officer
SaleOrdinary Shares 272 $20.00 $5,440.00
Disclosure

SEC source: 0001209191-23-052253 · doc4.xml · nonDerivative · entry 1

Keen Nicholas · CIK 0001776881 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,233

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 21:46 UTC
Lee KevinDirector · Chief Executive Officer
SaleOrdinary Shares 1,470 $20.00 $29,400.00
Disclosure

SEC source: 0001209191-23-052249 · doc4.xml · nonDerivative · entry 1

Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,131

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 21:50 UTC
Thompson Travis AlvinChief Accounting Officer
SaleOrdinary Shares 54 $20.00 $1,080.00
Disclosure

SEC source: 0001209191-23-052254 · doc4.xml · nonDerivative · entry 1

Thompson Travis Alvin · CIK 0001983944 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,979

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 21:48 UTC
Crockett NigelChief Business Officer
SaleOrdinary Shares 442 $20.00 $8,840.00
Disclosure

SEC source: 0001209191-23-052252 · doc4.xml · nonDerivative · entry 1

Crockett Nigel · CIK 0001788580 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,359

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 21:47 UTC
Milnes AlistairChief Operating Officer
SaleOrdinary Shares 442 $20.00 $8,840.00
Disclosure

SEC source: 0001209191-23-052251 · doc4.xml · nonDerivative · entry 1

Milnes Alistair · CIK 0001901321 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,839

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2023 Filed Oct 5, 2023 21:46 UTC
Skynner MichaelChief Technology Officer
SaleOrdinary Shares 442 $20.00 $8,840.00
Disclosure

SEC source: 0001209191-23-052248 · doc4.xml · nonDerivative · entry 1

Skynner Michael · CIK 0001776582 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,482

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 22:23 UTC
Young AlethiaChief Financial Officer
GrantEmployee Share Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $26.21 $0.00
Disclosure

SEC source: 0001209191-23-042789 · doc4.xml · derivative · entry 1

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Ordinary Shares · 120,000 shares

Expires 2033-07-17

F1 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on July 17, 2024 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 16:50 UTC
Keen NicholasChief Scientific Officer
SaleOrdinary Shares 336 $25.10 $8,433.60
Disclosure

SEC source: 0001209191-23-041570 · doc4.xml · nonDerivative · entry 1

Keen Nicholas · CIK 0001776881 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,505

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 20:51 UTC
Lee KevinDirector · Chief Executive Officer
SaleOrdinary Shares 1,498 $25.10 $37,599.80
Disclosure

SEC source: 0001209191-23-041571 · doc4.xml · nonDerivative · entry 1

Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,601

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 20:57 UTC
Thompson Travis AlvinChief Accounting Officer
SaleOrdinary Shares 61 $25.10 $1,531.10
Disclosure

SEC source: 0001209191-23-041578 · doc4.xml · nonDerivative · entry 1

Thompson Travis Alvin · CIK 0001983944 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,033

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 20:53 UTC
Skynner MichaelChief Technology Officer
SaleOrdinary Shares 451 $25.10 $11,320.10
Disclosure

SEC source: 0001209191-23-041574 · doc4.xml · nonDerivative · entry 1

Skynner Michael · CIK 0001776582 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,924

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 20:52 UTC
Milnes AlistairChief Operating Officer
SaleOrdinary Shares 451 $25.10 $11,320.10
Disclosure

SEC source: 0001209191-23-041573 · doc4.xml · nonDerivative · entry 1

Milnes Alistair · CIK 0001901321 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,281

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 20:49 UTC
Crockett NigelChief Business Officer
SaleOrdinary Shares 451 $25.10 $11,320.10
Disclosure

SEC source: 0001209191-23-041569 · doc4.xml · nonDerivative · entry 1

Crockett Nigel · CIK 0001788580 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,801

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.85 to $25.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 16:43 UTC
Keen NicholasChief Scientific Officer
SaleOrdinary Shares 319 $21.11 $6,734.09
Disclosure

SEC source: 0001209191-23-023352 · doc4.xml · nonDerivative · entry 1

Keen Nicholas · CIK 0001776881 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,841

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:39 UTC
Lee KevinDirector · Chief Executive Officer
SaleOrdinary Shares 1,486 $21.11 $31,369.46
Disclosure

SEC source: 0001209191-23-023342 · doc4.xml · nonDerivative · entry 1

Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,099

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:41 UTC
Kalowski LeePresident and CFO
SaleOrdinary Shares 376 $21.11 $7,937.36
Disclosure

SEC source: 0001209191-23-023347 · doc4.xml · nonDerivative · entry 1

Kalowski Lee · CIK 0001618273 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,309

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:43 UTC
Skynner MichaelChief Technology Officer
SaleOrdinary Shares 447 $21.11 $9,436.17
Disclosure

SEC source: 0001209191-23-023350 · doc4.xml · nonDerivative · entry 1

Skynner Michael · CIK 0001776582 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,375

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:42 UTC
Milnes AlistairChief Operating Officer
SaleOrdinary Shares 447 $21.11 $9,436.17
Disclosure

SEC source: 0001209191-23-023349 · doc4.xml · nonDerivative · entry 1

Milnes Alistair · CIK 0001901321 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,732

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:40 UTC
Crockett NigelChief Business Officer
SaleOrdinary Shares 447 $21.11 $9,436.17
Disclosure

SEC source: 0001209191-23-023344 · doc4.xml · nonDerivative · entry 1

Crockett Nigel · CIK 0001788580 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,252

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 16:12 UTC
Arroyo SantiagoChief Development Officer
GrantEmployee Stock Option (right to buy) · Derivative 120,000 $0.00 Strike: $21.77 $0.00
Disclosure

SEC source: 0001209191-23-022667 · doc4.xml · derivative · entry 1

Arroyo Santiago · CIK 0001706857 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Ordinary Shares · 120,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on the first anniversary of the date of grant and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the individual remaining a service provider of the issuer through each such date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:10 UTC GrantStock Option (right to buy) · Derivative 11,500 $0.00 Strike: $29.60 $0.00
Disclosure

SEC source: 0001209191-23-002187 · doc4.xml · derivative · entry 2

Bourque Janice · CIK 0001783330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Ordinary Shares · 11,500 shares

Expires 2033-01-03

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:10 UTC GrantOrdinary Shares 5,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002187 · doc4.xml · nonDerivative · entry 1

Bourque Janice · CIK 0001783330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,750

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC
Keen NicholasChief Scientific Officer
GrantEmployee Stock Option (right to buy) · Derivative 35,000 $0.00 Strike: $29.60 $0.00
Disclosure

SEC source: 0001209191-23-002193 · doc4.xml · derivative · entry 4

Keen Nicholas · CIK 0001776881 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Ordinary Shares · 35,000 shares

Expires 2033-01-03

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC
Keen NicholasChief Scientific Officer
SaleOrdinary Shares 1,817 $29.06 $52,802.02
Disclosure

SEC source: 0001209191-23-002193 · doc4.xml · nonDerivative · entry 2

Keen Nicholas · CIK 0001776881 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,160

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.545 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC
Keen NicholasChief Scientific Officer
GrantOrdinary Shares 17,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002193 · doc4.xml · nonDerivative · entry 1

Keen Nicholas · CIK 0001776881 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,977

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 3, 2024 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:06 UTC
Lee KevinDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 115,000 $0.00 Strike: $29.60 $0.00
Disclosure

SEC source: 0001209191-23-002178 · doc4.xml · derivative · entry 3

Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Ordinary Shares · 115,000 shares

Expires 2033-01-03

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:06 UTC
Lee KevinDirector · Chief Executive Officer
SaleOrdinary Shares 6,000 $29.06 $174,360.00
Disclosure

SEC source: 0001209191-23-002178 · doc4.xml · nonDerivative · entry 2

Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,585

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.545 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:06 UTC
Lee KevinDirector · Chief Executive Officer
GrantOrdinary Shares 57,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002178 · doc4.xml · nonDerivative · entry 1

Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,585

F1 · shares: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 3, 2024 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:07 UTC GrantStock Option (right to buy) · Derivative 11,500 $0.00 Strike: $29.60 $0.00
Disclosure

SEC source: 0001209191-23-002180 · doc4.xml · derivative · entry 2

Gutierrez-Ramos Jose-Carlos · CIK 0001667657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Ordinary Shares · 11,500 shares

Expires 2033-01-03

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:07 UTC GrantOrdinary Shares 5,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002180 · doc4.xml · nonDerivative · entry 1

Gutierrez-Ramos Jose-Carlos · CIK 0001667657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,750

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:12 UTC
Kalowski LeePresident and CFO
GrantEmployee Stock Option (right to buy) · Derivative 35,000 $0.00 Strike: $29.60 $0.00
Disclosure

SEC source: 0001209191-23-002190 · doc4.xml · derivative · entry 3

Kalowski Lee · CIK 0001618273 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Ordinary Shares · 35,000 shares

Expires 2033-01-03

F5 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:12 UTC
Kalowski LeePresident and CFO
SaleOrdinary Shares 1,815 $29.06 $52,743.90
Disclosure

SEC source: 0001209191-23-002190 · doc4.xml · nonDerivative · entry 2

Kalowski Lee · CIK 0001618273 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,685

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.545 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.